Rehmann Capital Advisory Group’s Select Medical SEM Stock Holding History

Rehmann Capital Advisory Group’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$795	Hold	89	–	–	﹤0.01%	1590
2019 Q2	$761	Hold	89	–	–	﹤0.01%	1955
2019 Q1	$676	Buy	89 +5	+6%	+$40	﹤0.01%	1985
2018 Q4	$690	Buy	+84	New	+$804	﹤0.01%	1712

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Rehmann Capital Advisory Group's SEM Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Select Medical (SEM) position steady in Q3 2019 at 89 shares worth $795. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Rehmann Capital Advisory Group first reported a position in SEM in Q4 2018 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold SEM as of Q3 2019.

Rehmann Capital Advisory Group held 89 shares of Select Medical worth $795 as of Q3 2019.
Rehmann Capital Advisory Group left its Select Medical share count unchanged in Q3 2019.
Select Medical made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1590 holding.
Rehmann Capital Advisory Group first reported a position in Select Medical in Q4 2018 and has held it in 4 quarters since.
187 funds tracked by Wall St. Rank held Select Medical as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.